Key Points
- Director Alexandre Weinstein Manieu bought 452,702 shares of Pluri at an average price of $4.61, a purchase valued at about $2,086,956.22 disclosed in an SEC filing.
- PLUR traded up ~9.2% (opened at $3.90) but the company shows financial strain — market cap ≈ $36.1M, negative EPS (‑$0.65), low liquidity (current and quick ratios 0.68) and a high debt-to-equity of 51.65.
- The street consensus is a "Hold" with an average target of $12.00 (one Buy, one Sell); Jane Street established a small new position of 10,928 shares and institutions own about 16.59% of the stock.
Pluri Inc. (NASDAQ:PLUR - Get Free Report) Director Alexandre Weinstein Manieu bought 452,702 shares of the stock in a transaction that occurred on Monday, April 28th. The stock was bought at an average price of $4.61 per share, with a total value of $2,086,956.22. Following the completion of the acquisition, the director owned 452,702 shares of the company's stock, valued at $2,086,956.22. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Pluri Trading Up 9.2%
PLUR stock opened at $3.90 on Friday. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 51.65. The company has a market cap of $36.09 million, a price-to-earnings ratio of -0.75 and a beta of 0.63. The business has a fifty day simple moving average of $4.20 and a 200-day simple moving average of $4.69. Pluri Inc. has a 52 week low of $3.22 and a 52 week high of $7.13.
Pluri (NASDAQ:PLUR - Get Free Report) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($0.65) earnings per share (EPS) for the quarter. The firm had revenue of $0.32 million for the quarter. Pluri had a negative net margin of 1,701.19% and a negative return on equity of 4,191.91%.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Pluri in a report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $12.00.
View Our Latest Stock Report on Pluri
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Pluri stock. Jane Street Group LLC acquired a new position in Pluri Inc. (NASDAQ:PLUR - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 10,928 shares of the company's stock, valued at approximately $47,000. Jane Street Group LLC owned about 0.14% of Pluri at the end of the most recent reporting period. Institutional investors and hedge funds own 16.59% of the company's stock.
Pluri Company Profile
(
Get Free Report)
Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
